(Q39377541)

11 September 2017

Transfer-factor therapy in multiple sclerosis (English)

1 reference

11 September 2017

0 references

P O Behan

1

1 reference

11 September 2017

W F Durward

2

1 reference

11 September 2017

I D Melville

3

1 reference

11 September 2017

A P McGeorge

4

1 reference

11 September 2017

W M Behan

5

1 reference

11 September 2017

language of work or name

English

0 references

publication date

1 May 1976

1 reference

11 September 2017

1 reference

11 September 2017

1

1 reference

11 September 2017

7967

1 reference

11 September 2017

988-990

1 reference

Antibodies to measles antigen, control antigen, and monkey kidney antigen. Studies in patients with multiple sclerosis and other neurological diseases and normal healthy individuals.

11 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991861-4

7 January 2021

Virus antibody levels in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991861-4

7 January 2021

A suppression of cellular immunity in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991861-4

7 January 2021

Measles Antibodies in the Cerebrospinal Fluid of Patients with Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991861-4

7 January 2021

Fusion of cultured multiple-sclerosis brain cells with indicator cells: presence of nucleocapsids and virions and isolation of parainfluenza-type virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991861-4

7 January 2021

Paramyxovirus-Like Particles Associated with Acute Demyelination in Chronic Relapsing Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991861-4

7 January 2021

Histocompatibility determinants in multiple sclerosis, with special reference to clinical course

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991861-4

7 January 2021

Critique of experimental trials of therapy in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991861-4

7 January 2021

Immunological Features in a Case of Subacute Sclerosing Panencephalitis Treated with Transfer Factor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991861-4

7 January 2021

Lymphocyte trnsformation induced by encephalitogenic factor in multiple sclerosis and other neurological diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991861-4

7 January 2021

10.1016/S0140-6736(76)91861-4

Identifiers

DOI

1 reference

11 September 2017

1 reference